Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 3/20 | 0.45 |
| ▸ | RARB | P10826 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 6/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.38 |
| ▸ | RELA | Q04206 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11979778 | 0.99 | RARB (0.47) | GCGRRARBRAB9ASMN1; SMN2MAPT | |
| SCHEMBL11979777 | 0.99 | RARB (0.47) | GCGRRARBRAB9ASMN1; SMN2MAPT | |
| SCHEMBL11979779 | 0.99 | RARB (0.47) | GCGRRARBRAB9ASMN1; SMN2MAPT | |
| SCHEMBL9399411 | 0.90 | RARB (0.48) | RARBRAB9ASMN1; SMN2MAPTGAA | |
| SCHEMBL9399034 | 0.88 | RARB (0.50) | RARBRAB9ASMN1; SMN2MAPTGAA | |
| SCHEMBL9398666 | 0.87 | RARB (0.49) | RARBRAB9ASMN1; SMN2MAPTGAA | |
| SCHEMBL9398829 | 0.87 | RARB (0.46) | RARBRAB9ASMN1; SMN2MAPTGAA | |
| SCHEMBL8555801 | 0.85 | RAB9A (0.49) | RARBRAB9ASMN1; SMN2MAPTGAA | |
| SCHEMBL9399921 | 0.84 | RARB (0.52) | GCGRRARBRAB9ASMN1; SMN2MAPT | |
| SCHEMBL17225150 | 0.83 | RARB (0.52) | GCGRRARBRAB9ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8993754-B2 | Iridium complex and light emitting material formed from same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20120208999-A1 | IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208999-A1 | IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME | LUC7L2, CRY1, INTS9 | GCGR 4385/4885RARB 3014/4885RAB9A 1983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.